dc.creatorHerrera M.I.
dc.creatorKölliker-Frers R.A.
dc.creatorOtero-Losada M.
dc.creatorPerez Lloret S.
dc.creatorFilippo M.
dc.creatorTau J.
dc.creatorCapani F.
dc.creatorVilla A.M.
dc.date.accessioned2020-09-02T22:20:27Z
dc.date.accessioned2022-11-08T20:19:20Z
dc.date.available2020-09-02T22:20:27Z
dc.date.available2022-11-08T20:19:20Z
dc.date.created2020-09-02T22:20:27Z
dc.date.issued2019
dc.identifier10, , -
dc.identifier16642295
dc.identifierhttps://hdl.handle.net/20.500.12728/4874
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5143118
dc.languageen
dc.publisherFrontiers Media S.A.
dc.subjectbiomarker potential
dc.subjectcytokines
dc.subjectdisability progression
dc.subjectexpanded disability status scale
dc.subjectneurofilament heavy chain phosphoform
dc.subjectrelapsing-remitting multiple sclerosis
dc.subjectcytokine
dc.subjectintercellular adhesion molecule 1
dc.subjectinterleukin 17
dc.subjectinterleukin 1beta
dc.subjectinterleukin 6
dc.subjectinterleukin 8
dc.subjectmonocyte chemotactic protein 1
dc.subjectneurofilament H protein
dc.subjectneurofilament protein
dc.subjecttransforming growth factor beta1
dc.subjecttumor necrosis factor
dc.subjectunclassified drug
dc.subjectadult
dc.subjectArticle
dc.subjectaxonal injury
dc.subjectcase study
dc.subjectclinical article
dc.subjectclinical evaluation
dc.subjectcontrolled study
dc.subjectcorrelational study
dc.subjectcross-sectional study
dc.subjectdeterioration
dc.subjectdisease exacerbation
dc.subjectdisease marker
dc.subjectenzyme linked immunosorbent assay
dc.subjectExpanded Disability Status Scale
dc.subjectfeasibility study
dc.subjectfemale
dc.subjecthuman
dc.subjectimmunomodulation
dc.subjectmale
dc.subjectmetabolic disorder
dc.subjectmultiple sclerosis
dc.subjectobservational study
dc.subjectpilot study
dc.subjectprotein blood level
dc.subjectprotein phosphorylation
dc.subjectscoring system
dc.titleA Pilot Cross-Sectional Study to Investigate the Biomarker Potential of Phosphorylated Neurofilament-H and Immune Mediators of Disability in Patients With 5 Year Relapsing-Remitting Multiple Sclerosis
dc.typeArticle


Este ítem pertenece a la siguiente institución